Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2000
12/20/2000CN1059557C A medical preparation containing goose egg for treating osteoproliferation
12/20/2000CN1059556C Compound cinobufogin
12/20/2000CN1059555C Preparation for compound sodium fulvate injecta
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162643 Serum-free mixture of 2-(4-(2-hydroxyethyl)piperazinyl) ethanesulfonic acid at concentration of 16-22 mm, sodium chloride at 90-140 mm, and a protease; for production of epithelial tissues like epidermis, cornea, gingiva and ureter
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162428 hNT-neuron human neuronal cells to replace ganglion cells
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075351A1 Siv-based packaging-defficient vectors
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075292A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000WO2000075291A2 Cells with enforced expression of bcl-xl
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
12/14/2000WO2000075275A2 Bioreactor design and process for engineering tissue from cells
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075183A1 Product from starfish
12/14/2000WO2000074741A2 Biological joint construct
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074713A1 Autologous thrombin
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074693A2 Immunity generation
12/14/2000WO2000074692A1 A method using potassium dihydrogen phosphate to reduce calcification of tissue
12/14/2000WO2000074690A1 Bone graft substitute composition
12/14/2000WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000WO2000074584A1 Devices and methods for treating tissue
12/14/2000WO2000074483A1 Improved storage and maintenance of blood products including red blood cells and platelets
12/14/2000WO2000074478A1 Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application
12/14/2000WO2000050570A3 Compositions and methods for modulating growth or differentiation of growth-factor dependent cells
12/14/2000WO2000049141A3 A method for production and delivery of a protein in vivo
12/14/2000WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation
12/14/2000WO2000048615A3 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000WO2000039135A3 Insulin mimetics from honey
12/14/2000WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
12/14/2000DE19926083A1 Biologisches Gelenkkonstrukt The biological joint construct
12/14/2000DE19926074A1 Therapeutic solution, especially for cancer treatment, obtained by heating and pulverizing tumor tissue and dissolving product in aqueous solution
12/14/2000DE19925996A1 Verfahren und Vorrichtung zur Herstellung des Sekrets von Fliegenlarven für die therapeutische Applikation Method and apparatus for the production of the secretion of the fly larvae for therapeutic application
12/14/2000DE10025867A1 Increasing performance-related activity, reducing general inactivity and improving general health, using kombucha as alpha-rhythm modulator
12/14/2000CA2376939A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000CA2376790A1 Siv-based packaging-defficient vectors
12/14/2000CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376039A1 Bioreactor design and process for engineering tissue from cells
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy
12/14/2000CA2373277A1 Immunity generation
12/14/2000CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/13/2000EP1058725A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
12/13/2000EP1058563A1 Systems and methods for obtaining a uniform targeted volume of concentrated red blood cells
12/13/2000EP1058555A1 Costimulatory blockade and mixed chimerism in allotransplantation
12/13/2000EP1058554A2 Nontoxic vernix compositions and method of producing
12/13/2000EP0927196A4 Polymers containing polysaccharides such as alginates or modified alginates
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system
12/13/2000CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems
12/13/2000CN1276725A Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma
12/13/2000CN1276242A Chinese medicine for curing cough and asthma
12/13/2000CN1276239A Anticancer pill and its preparing process
12/13/2000CN1276234A Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process
12/13/2000CN1276227A Process for preparing Chinese medicine preparation of treating pyelonephritis
12/13/2000CN1276226A Plaster for treating cancer and tumor
12/13/2000CN1276225A 'Chanhoukang' for postpartum recovery and its preparing process
12/13/2000CN1276223A Bone setting capsule and its preparing process
12/13/2000CN1276221A Anal fissure ointment and its preparing process
12/13/2000CN1276220A Chinese-medicinal capsule for preventing and treating cerebral apoplexy
12/13/2000CN1276213A Medicine for treating diseases in chicken respiratory tract
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/13/2000CN1059346C Chinese herb medicine for external use of gynecopathy
12/13/2000CN1059344C Health medicinal liquor and preparation method thereof
12/13/2000CN1059339C Chinese medicine for treatment of migraine and method for preparing same
12/13/2000CN1059338C Chinese medicine for treating cerebral vascular diseases and its producing method
12/13/2000CN1059333C Chinese patent drug for various cancers and tumors
12/13/2000CN1059325C Health-care beer
12/13/2000CN1059324C Bones and tendon recovery cream
12/12/2000US6160093 Microorganism polypeptide; for the prevention, treatment and diagnosis of microorganismal infection; for use in immunotherapy; anticarcinogenic agents
12/12/2000US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses
12/12/2000US6159701 Imaging tumor cells in vivo by obtaining sample of monocytes, macrophages, or splenocytes; priming the cells; labeling with radiolabelled a1 adenosine receptor agonist which induces cytotoxicity in the cells; administering to patient
12/12/2000US6159504 Producing, by electrostatic attraction, micro calcium-containing shells on the surfaces of droplets of an emulsion comprising oil; replacing oil with other solvent, drying, introducing core substance into the hollow
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159495 Used as a wound dressing, a tissue-engineering scaffold, a diffusion membrane, a coating for implantable devices, a cell encapsulant, and a cross-linked implantable biomaterial for soft and hard tissue replacement
12/12/2000US6159465 Epithelial adhesive lactobacilli
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159443 X-ray guided drug delivery
12/09/2000CA2308691A1 Live attenuated bacteria for use in a vaccine
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000WO2000073480A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus